Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3010% above fair value
$101.59+0.34 (+0.34%)
Close on Nov 13, 2026Market cap $6.63BP/E 25.1Yield –
Lantheus cash
Cash and short-term investments held at the end of each period.
Lantheus's cash was $683.61M at Sep 30, 2026. For fiscal 2025 it was $359.12M, down 60.7% from the year before. Over ten years it grew 28.8% a year on average. The highest annual figure on record is $914.49M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $359.12M | -60.7% |
| FY2024 | Dec 31, 2024 | $914.49M | +28.1% |
| FY2023 | Dec 31, 2023 | $713.66M | +71.0% |
| FY2022 | Dec 31, 2022 | $417.24M | +314.5% |
| FY2021 | Dec 31, 2021 | $100.65M | +21.7% |
| FY2020 | Dec 31, 2020 | $82.69M | -11.0% |
| FY2019 | Dec 31, 2019 | $92.92M | -18.1% |
| FY2018 | Dec 31, 2018 | $113.40M | +48.6% |
| FY2017 | Dec 31, 2017 | $76.29M | +49.1% |
| FY2016 | Dec 31, 2016 | $51.18M | +79.0% |
| FY2015 | Dec 31, 2015 | $28.60M | +44.9% |
| FY2014 | Dec 31, 2014 | $19.74M | +6.2% |
| FY2013 | Dec 31, 2013 | $18.58M | -44.2% |
| FY2012 | Dec 31, 2012 | $33.32M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $683.61M | +79.0% |
| Q2 FY2026 | Jun 30, 2026 | $593.30M | -14.7% |
| Q1 FY2026 | Mar 31, 2026 | $595.02M | -14.7% |
| Q4 FY2025 | Dec 31, 2025 | $359.12M | -60.7% |
| Q3 FY2025 | Sep 30, 2025 | $382.01M | -55.9% |
| Q2 FY2025 | Jun 30, 2025 | $695.57M | -8.1% |
| Q1 FY2025 | Mar 31, 2025 | $697.26M | -2.9% |
| Q4 FY2024 | Dec 31, 2024 | $914.49M | +28.1% |
| Q3 FY2024 | Sep 30, 2024 | $866.39M | +41.1% |
| Q2 FY2024 | Jun 30, 2024 | $757.02M | +82.8% |
| Q1 FY2024 | Mar 31, 2024 | $718.28M | +52.5% |
| Q4 FY2023 | Dec 31, 2023 | $713.66M | +71.0% |
| Q3 FY2023 | Sep 30, 2023 | $614.13M | +138.7% |
| Q2 FY2023 | Jun 30, 2023 | $414.08M | +141.5% |
| Q1 FY2023 | Mar 31, 2023 | $470.86M | +346.9% |
| Q4 FY2022 | Dec 31, 2022 | $417.24M | +314.5% |
| Q3 FY2022 | Sep 30, 2022 | $257.26M | +181.2% |
| Q2 FY2022 | Jun 30, 2022 | $171.43M | +87.4% |
| Q1 FY2022 | Mar 31, 2022 | $105.36M | +53.0% |
| Q4 FY2021 | Dec 31, 2021 | $100.65M | +21.7% |
| Q3 FY2021 | Sep 30, 2021 | $91.48M | +4.0% |
| Q2 FY2021 | Jun 30, 2021 | $91.50M | +1.3% |
| Q1 FY2021 | Mar 31, 2021 | $68.86M | -28.1% |
| Q4 FY2020 | Dec 31, 2020 | $82.69M | -11.0% |
| Q3 FY2020 | Sep 30, 2020 | $87.99M | +12.7% |
| Q2 FY2020 | Jun 30, 2020 | $90.31M | +58.8% |
| Q1 FY2020 | Mar 31, 2020 | $95.71M | -14.6% |
| Q4 FY2019 | Dec 31, 2019 | $92.92M | -18.1% |
| Q3 FY2019 | Sep 30, 2019 | $78.06M | -25.4% |
| Q2 FY2019 | Jun 30, 2019 | $56.89M | -34.2% |
| Q1 FY2019 | Mar 31, 2019 | $112.06M | +52.0% |
| Q4 FY2018 | Dec 31, 2018 | $113.40M | +48.6% |
| Q3 FY2018 | Sep 30, 2018 | $104.58M | +53.6% |
| Q2 FY2018 | Jun 30, 2018 | $86.46M | +51.3% |
| Q1 FY2018 | Mar 31, 2018 | $73.74M | +80.4% |
| Q4 FY2017 | Dec 31, 2017 | $76.29M | +49.1% |
| Q3 FY2017 | Sep 30, 2017 | $68.08M | – |
| Q2 FY2017 | Jun 30, 2017 | $57.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $40.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $51.18M | – |
See a number that looks wrong?